I attended a panel of the scientists that do the research and trials for cancer gene therapy, which ACGT helps fund, and I am a vendor of this organization - they are my client. All of the company and its volunteers attended the recent panel event and are engaged and passionate, knowledgeable about their efforts to fund and bring advancements in cancer gene therapy and to help patients thrive, not just survive.
They are the only charitable organization in the United States that is dedicated exclusively to cell and gene-based therapies for cancer. They have funded 17 research projects that have been approved for human clinical trials, and 11 of these trials have started. These trials provide scientists and patients with the opportunity to put research into practice – and save lives. 100% of donations to ACGT go directly toward research endeavors. Funding for administrative and fundraising costs is provided separately. $23,200,000 has been awarded for ACGT endeavors. Of that, $11.3 million has gone toward discovery and research, and $11.9 million has gone toward translation into treatments.
Review from Guidestar